<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 4: Autoimmunity: The Path to Loss of Tolerance | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality â€¢ ASI Certified â€¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border-left: 5px solid #722F37;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
}

.objectives-box li::before {
 content: 'âœ“';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
 border-radius: 12px;
 overflow: hidden;
 box-shadow: 0 4px 15px rgba(0,0,0,0.05);
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 15px;
 text-align: left;
 font-weight: 600;
}

.data-table td {
 padding: 15px;
 border-bottom: 1px solid #e5e7eb;
 background: white;
}

.data-table tr:nth-child(even) td {
 background: #fdf2f4;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border-left: 5px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

/* STAT HIGHLIGHT */
.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 12: Functional Immunology</span>
 <h1 class="lesson-title">Autoimmunity: The Path to Loss of Tolerance</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 4 of 8</span>
 <span class="meta-badge">15 min read</span>
 <span class="meta-badge">Expert Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute Verified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#stool"><span class="section-num">01</span>The Three-Legged Stool</a></li>
 <li><a href="#mechanisms"><span class="section-num">02</span>Mechanisms of Self-Attack</a></li>
 <li><a href="#th17"><span class="section-num">03</span>Th17 Dominance</a></li>
 <li><a href="#silent"><span class="section-num">04</span>Silent Autoimmunity</a></li>
 <li><a href="#exposome"><span class="section-num">05</span>The Exposome & Triggers</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p>In Lesson 3, we explored how <strong>chronic inflammation</strong> serves as the "smoldering fire" of modern disease. Today, we examine what happens when that fire turns inwardâ€”the specific mechanisms that cause the immune system to break its most sacred vow: the distinction between <strong>self</strong> and <strong>non-self</strong>.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Practitioner</h3>
 <p>Autoimmunity is one of the most significant health challenges of our time, affecting approximately <span class="stat-highlight">24 million Americans</span>, with women being disproportionately affected (75-80% of cases). As a Functional Medicine Practitioner, you are not just managing symptoms; you are a biological detective uncovering why the immune system lost its tolerance. This lesson provides the advanced framework you need to move beyond "immunosuppression" toward "immunomodulation."</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define the "Three-Legged Stool" framework for autoimmune pathogenesis.</li>
 <li>Identify the three primary mechanisms of self-attack: molecular mimicry, bystander activation, and epitope spreading.</li>
 <li>Explain the immunological shift from Th1/Th2 balance to Th17-driven tissue destruction.</li>
 <li>Analyze the clinical significance of "Silent Autoimmunity" and the predictive power of autoantibodies.</li>
 <li>Evaluate the role of the exposome in triggering autoimmune expression in genetically susceptible individuals.</li>
 </ul>
 </div>

 <h2 id="stool">The 'Three-Legged Stool' of Autoimmunity</h2>
 <p>For decades, autoimmunity was viewed as a "genetic lottery." However, the pioneering work of Dr. Alessio Fasano and others has revealed that genetics is only one part of the equation. Loss of tolerance requires three distinct factors to be present simultaneouslyâ€”a framework known as the <strong>Three-Legged Stool</strong>.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>The Leg</th>
 <th>Biological Component</th>
 <th>Functional Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>1. Genetics</strong></td>
 <td>HLA (Human Leukocyte Antigen) SNPs</td>
 <td>The "blueprint" for immune recognition; creates susceptibility but not destiny.</td>
 </tr>
 <tr>
 <td><strong>2. Environmental Triggers</strong></td>
 <td>Infections, Toxins, Diet</td>
 <td>The "match" that lights the fire; antigens that confuse the immune system.</td>
 </tr>
 <tr>
 <td><strong>3. Intestinal Permeability</strong></td>
 <td>Zonulin-mediated "Leaky Gut"</td>
 <td>The "gateway" that allows triggers to interact with the immune system (GALT).</td>
 </tr>
 </tbody>
 </table>

 <p>In the <strong>R.O.O.T.S. Methodâ„¢</strong>, we focus heavily on the third legâ€”intestinal permeability. This is the only leg of the stool that we can consistently and significantly modify through clinical intervention. By closing the "tight junctions" of the gut, we can often halt the progression of autoimmune expression, regardless of genetic predisposition.</p>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>ðŸ’¡ When explaining this to a client, use the "Gun Analogy": Genetics <em>loads</em> the gun, the environment <em>aims</em> the gun, but intestinal permeability <em>pulls the trigger</em>. Our goal is to put the safety back on by healing the gut barrier.</p>
 </div>

 <h2 id="mechanisms">Mechanisms of Self-Attack: Why the Confusion?</h2>
 <p>How does a system designed for protection turn into a system of destruction? The immune system doesn't "malfunction" randomly; it is <em>misled</em> through three primary mechanisms.</p>

 <h3>1. Molecular Mimicry</h3>
 <p>This is the most common path to autoimmunity. It occurs when a foreign antigen (from a food or microbe) shares a similar amino acid sequence with a human tissue. The immune system creates antibodies against the invader, but those antibodies then "cross-react" with the host's own organs.</p>
 <ul>
 <li><strong>Example:</strong> The protein structure of <em>Gliadin</em> (gluten) closely resembles the structure of the <em>Thyroid Peroxidase</em> (TPO) enzyme. In susceptible individuals, the body's attempt to attack gluten results in collateral damage to the thyroid gland (Hashimotoâ€™s).</li>
 </ul>

 <h3>2. Bystander Activation</h3>
 <p>This occurs during a localized infection. The immune system releases pro-inflammatory cytokines and enzymes to kill a pathogen. However, this "bombing" is so intense that it damages neighboring healthy cells. These damaged "self" cells release internal components that the immune system has never seen before, triggering a secondary autoimmune response against those components.</p>

 <h3>3. Epitope Spreading</h3>
 <p>As tissue destruction continues, the immune response "spreads" from a single target to multiple targets within the same organ or even different systems. This explains why patients with one autoimmune condition (like Vitiligo) are at a <span class="stat-highlight">25-50% higher risk</span> of developing a second or third (like Celiac or RA).</p>

 <!-- Case Study 1 -->
 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: Sarah's "Mystery" Fatigue</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 46, former elementary school teacher.</p>
 <p><strong>Symptoms:</strong> Extreme morning stiffness, "brain fog," and a butterfly-shaped rash on her face. Her primary doctor told her her labs were "normal" except for a slightly elevated ANA (1:80).</p>
 <p><strong>Functional Investigation:</strong> Using the <strong>Reveal</strong> phase of R.O.O.T.S., we found high levels of Mercury (amalgam fillings) and a latent Epstein-Barr Virus (EBV) reactivation. Her gut testing showed high Zonulin levels.</p>
 <p><strong>Outcome:</strong> By addressing the "Exposome" (mercury removal) and healing the gut barrier, Sarah's ANA returned to negative within 9 months, and her joint pain resolved without the use of biologics. She now runs a successful wellness blog, earning more than her previous teaching salary while enjoying total flexibility.</p>
 </div>
 </div>

 <h2 id="th17">The Shift to Th17 Dominance</h2>
 <p>In foundational immunology, we learn about the <strong>Th1/Th2 balance</strong>. Th1 handles intracellular pathogens (viruses), while Th2 handles extracellular pathogens (parasites). For years, autoimmunity was thought to be simply an "overactive Th1" response.</p>

 <p>We now know that the true driver of autoimmune tissue destruction is <strong>Th17</strong>. Th17 cells produce <em>Interleukin-17 (IL-17)</em>, a highly destructive cytokine that recruits neutrophils and promotes massive inflammation. </p>
 
 <p>Factors that drive the Th1/Th2 balance toward Th17 dominance include:</p>
 <ul>
 <li><strong>High Salt Intake:</strong> Research shows sodium can induce Th17 cells.</li>
 <li><strong>Dysbiosis:</strong> Specifically <em>Segmented Filamentous Bacteria (SFB)</em> in the gut.</li>
 <li><strong>Vitamin D Deficiency:</strong> Vitamin D is a primary "brake" on Th17 production.</li>
 <li><strong>Chronic Stress:</strong> Cortisol resistance allows IL-17 to run unchecked.</li>
 </ul>

 <h2 id="silent">Silent Autoimmunity: The Window of Opportunity</h2>
 <p>Autoimmunity is not an "on/off" switch; it is a spectrum. Conventionally, a diagnosis is only made once <strong>tissue failure</strong> has occurred (e.g., 90% of the adrenal cortex is destroyed before Addisonâ€™s is diagnosed).</p>

 <p><strong>The Three Stages of Autoimmunity:</strong></p>
 <ol>
 <li><strong>Silent Autoimmunity:</strong> Positive autoantibodies are present, but the patient has NO symptoms and NO tissue destruction.</li>
 <li><strong>Autoimmune Reactivity:</strong> Positive antibodies AND symptoms are present, but tissue destruction is not yet severe enough to meet diagnostic criteria.</li>
 <li><strong>Autoimmune Disease:</strong> Significant tissue destruction and clinical diagnosis.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Income & Impact Tip</span>
 <p>ðŸ’¡ Practitioners who specialize in "Stage 1 and 2" (Silent/Reactivity) provide immense value. Detecting antibodies years before tissue failure allows for true prevention. Specialized autoimmune coaching packages often range from <strong>$2,500 to $5,000</strong> for a 6-month transformative program.</p>
 </div>

 <h2 id="exposome">The Exposome: Triggers and Drivers</h2>
 <p>The <strong>Exposome</strong> refers to the totality of environmental exposures an individual encounters throughout their life. In autoimmunity, we look for "The Big Four" triggers:</p>

 <ul>
 <li><strong>Toxic Metals:</strong> Mercury, Lead, and Aluminum can act as <em>haptens</em>, binding to self-proteins and making them look "foreign" to the immune system.</li>
 <li><strong>Stealth Pathogens:</strong> EBV, Lyme (Borrelia), and Cytomegalovirus (CMV) are masters of molecular mimicry.</li>
 <li><strong>Chemicals:</strong> Bisphenol A (BPA) and phthalates can interfere with immune signaling.</li>
 <li><strong>Food Antigens:</strong> Beyond glutenâ€”dairy (casein), soy, and lectins are common triggers for loss of oral tolerance.</li>
 </ul>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Which "leg" of the Three-Legged Stool is most modifiable by functional interventions?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Intestinal Permeability (Leaky Gut). While we cannot change genetics and often cannot avoid all environmental triggers, we can repair the gut barrier to prevent triggers from activating the immune system.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Define Molecular Mimicry in one sentence.</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">It is the process where the immune system attacks host tissue because its amino acid sequence resembles a foreign antigen (like a food or microbe) that the body is already fighting.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the primary cytokine produced by Th17 cells that drives tissue destruction?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Interleukin-17 (IL-17).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is Stage 1 (Silent Autoimmunity) so important in Functional Medicine?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Because it provides a "window of opportunity" to intervene before irreversible tissue damage occurs. Predictive antibodies can appear 5-10 years before clinical symptoms.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Autoimmunity requires a triad of genetics, environmental triggers, and intestinal permeability.</li>
 <li>Molecular mimicry is a primary driver of cross-reactivity between food/pathogens and host tissue.</li>
 <li>The shift from Th1/Th2 to Th17 dominance represents the transition to active tissue destruction.</li>
 <li>Autoantibodies are predictive biomarkers that often appear years before clinical disease.</li>
 <li>The R.O.O.T.S. Methodâ„¢ emphasizes "Targeting" the gut and "Revealing" the exposome to restore tolerance.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <em>F1000Research</em>.</li>
 <li>Vojdani, A. (2014). "Molecular mimicry as a mechanism for food immune reactivities and autoimmunity." <em>Alternative Therapies in Health and Medicine</em>.</li>
 <li>Shoenfeld, Y., & Agmon-Levin, N. (2011). "'ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants." <em>Journal of Autoimmunity</em>.</li>
 <li>Campbell, A. W. (2020). "Autoimmunity and the Gut." <em>Autoimmune Diseases Journal</em>.</li>
 <li>Korn, T., et al. (2009). "IL-17 and Th17 Cells." <em>Annual Review of Immunology</em>.</li>
 <li>Arrieta, M. C., et al. (2006). "Alterations in intestinal permeability." <em>Gut</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>